m6A-centered Disease Response Information
General Information of the Disease (ID: M6ADIS0013)
Name |
Ovarian dysfunction
|
||||
---|---|---|---|---|---|
ICD |
ICD-11: 5A80
|
Full List of Target Gene(s) of This m6A-centered Disease Response
Flotillin-2 (FLOT2)
In total 1 item(s) under this target gene | ||||
Experiment 1 Reporting the m6A-centered Disease Response by This Target Gene | [1] | |||
Response Summary | FTO induced the dysfunctions of GCs by upregulating Flotillin-2 (FLOT2), suggesting that FTO/FLOT2 plays a role in the pathophysiology of polycystic ovarian syndrome. | |||
Responsed Disease | Polycystic ovary syndrome [ICD-11: 5A80.1] | |||
Target Regulator | Fat mass and obesity-associated protein (FTO) | ERASER | ||
Target Regulation | Up regulation | |||
Cell Process | Cell apoptosis | |||
In-vitro Model | KGN | Ovarian granulosa cell tumor | Homo sapiens | CVCL_0375 |
Forkhead box protein O3 (FOXO3)
In total 1 item(s) under this target gene | ||||
Experiment 1 Reporting the m6A-centered Disease Response by This Target Gene | [2] | |||
Response Summary | Altered m6 A modification was involved in up-regulated expression of Forkhead box protein O3 (FOXO3) mRNA in the luteinized granulosa cells from non-obese polycystic ovary syndrome patients following controlled ovarian hyperstimulation. | |||
Responsed Disease | Ovarian dysfunction [ICD-11: 5A80] | |||
Pathway Response | FoxO signaling pathway | hsa04068 | ||
In-vitro Model | Granulosa cell (A group of somatic cells in the follicle that interact with the oocyte and promote oogenesis) | |||
Intersectin-2 (ITSN2)
In total 1 item(s) under this target gene | ||||
Experiment 1 Reporting the m6A-centered Disease Response by This Target Gene | [3] | |||
Response Summary | METTL3 targets Intersectin-2 (ITSN2) for m6A modification and then enhances its stability to influence the oocytes meiosis. mRNA m6A modification in follicle development and coordination of RNA stabilization during oocyte growth. | |||
Responsed Disease | Ovarian dysfunction [ICD-11: 5A80] | |||
Target Regulator | Methyltransferase-like 3 (METTL3) | WRITER | ||
Target Regulation | Up regulation | |||
In-vivo Model | All mice described above were maintained on the C57BL/6 J background. Mice lacking Mettl3 in oocytes (referred to as Mettl3Gdf9 cKO) were generated by crossing Mettl3flox/flox mice with Gdf9-Cre mice. The Mettl3flox/flox female mice were used as the control group (referred to as WT). For the fertility test, six pairs of 6 weeks Mettl3flox/flox and Mettl3Gdf9 cKO female mice were randomly selected and continually mated to Mettl3flox/flox male mice which have been confirmed fertility for 5 months. The number of pups and litter size from each female was recorded. | |||
Mimecan (OGN)
In total 1 item(s) under this target gene | ||||
Experiment 1 Reporting the m6A-centered Disease Response by This Target Gene | [4] | |||
Response Summary | Correlation analysis indicated that Mimecan (OGN) function is closely related to m6A and ferroptosis. The hub gene OGN represent a significant gene involved in OC and PCOS progression by regulating the hormonal response. | |||
Responsed Disease | Polycystic ovary syndrome [ICD-11: 5A80.1] | |||
Cell Process | Hormonal response | |||
In-vitro Model | SK-OV-3 | Ovarian serous cystadenocarcinoma | Homo sapiens | CVCL_0532 |
KGN | Ovarian granulosa cell tumor | Homo sapiens | CVCL_0375 | |
References